Phase II study of a fixed dose-rate infusion of gemcitabine associated with uracil/tegafur in advanced carcinoma of the pancreas. [electronic resource]
Producer: 20030320Description: 1756-62 p. digitalISSN:- 0923-7534
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Biopsy, Needle
- Deoxycytidine -- administration & dosage
- Dose-Response Relationship, Drug
- Female
- Follow-Up Studies
- Humans
- Infusions, Intravenous
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Invasiveness -- pathology
- Neoplasm Staging
- Pancreatic Neoplasms -- drug therapy
- Probability
- Statistics, Nonparametric
- Survival Analysis
- Tegafur -- administration & dosage
- Treatment Outcome
- Uracil -- administration & dosage
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.